{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-031819","form_type":"8-K","ticker":"FHTX","cik":"0001822462","company_name":"Foghorn Therapeutics Inc.","filed_at":"2025-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.933175+00:00","generated_at":"2026-05-19T05:02:35.099400+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Foghorn Therapeutics stockholders elect four Class II directors, ratify Deloitte as auditor","bullets":["Elected Stuart Duty, Neil J. Gallagher, Adrian Gottschalk, and Ian F. Smith as Class II directors for three-year terms.","Votes for nominees ranged from 30.9M (Ian F. Smith) to 34.6M (Neil J. Gallagher); 8.68M broker non-votes.","Ratified Deloitte & Touche LLP as independent auditor for FY2025 with 43.34M votes for, 16,978 against.","Total shares present at meeting: 43,369,822 out of 55,721,340 outstanding; all proposals approved."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-031819","json":"https://secwatch.observer/filing/0001628280-25-031819.json","markdown":"https://secwatch.observer/filing/0001628280-25-031819.md","text":"https://secwatch.observer/filing/0001628280-25-031819.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1822462/000162828025031819/0001628280-25-031819-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1822462/000162828025031819/fhtx-20250617.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T05:02:35.099400+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}